Skip to main content
Log in

Visuo-constructional functions in patients with mild cognitive impairment, Alzheimer’s disease, and Parkinson’s disease

Visuo-konstruktive Funktionen in Patienten mit Mild Cognitive Impairment, Alzheimerkrankheit, und Parkinson Krankheit

  • Original Article
  • Published:
neuropsychiatrie Aims and scope Submit manuscript

Summary

Background

Several recently proposed criteria for assessing cognitive disorder require measuring the cognitive domain of visuo-constructional function. The aims of the present study were to develop a new test (Vienna Visuo-constructional Test—VVT) measuring visuo-constructional functions and to determine the reliability and validity of the VVT in patients with mild cognitive impairment (MCI), Parkinson’s disease (PD), and Alzheimer’s disease (AD). We further examined age and sex effects and the psychometric quality of the VVT.

Methods

The study included 76 healthy controls and 103 patients who were referred to the Department of Neurology, Medical University of Vienna for neurocognitive assessment. An administering and scoring system for the VVT was developed.

Results

Internal consistency (Cronbach’s alpha) was found to range from 0.82 for the healthy control group to 0.93 for the total patient group. There was no sex effect, but age had a negative effect on VVT performance. The VVT successfully differentiated healthy controls from MCI patients, AD patients, and PD patients, respectively.

Conclusion

The VVT shows satisfactory validity and reliability and can be administered easily in clinical practice. It constitutes a new measure that can successfully be used to identify visuo-constructional problems in patients with cognitive dysfunction.

Zusammenfassung

Hintergrund

Mehrere kürzlich vorgeschlagenen Klassifikationsschemeta zur Beurteilung kognitiver Störung fordern die Erfassung der kognitiven Domäne „visuo-konstruktive Funktionen“. Das Ziel der vorliegenden Studie war die Entwicklung eines neuen Tests (Vienna Visuo-Constructional Test—VVT) zur Messung visuo-konstruktiver Funktionen. Mithilfe der VVT wurden bei Patienten mit leichter kognitiver Beeinträchtigung (MCI), Parkinson-Krankheit (PD) und Alzheimer (AD) die visuo-konstruktiven Fähigkeiten untersucht. Des Weiteren wurden Alters- und Geschlechtseffekte und die psychometrische Qualität des VVT bestimmt.

Methoden

Die Studie umfasste 76 gesunde Kontrollpersonen und 103 Patienten, die sich an der Universitätsklinik für Neurologie, Medizinische Universität Wien einer neurologischen Untersuchung unterzogen. Ein neuartiges Auswertungssystem für die VVT wurde entwickelt.

Ergebnisse

Die interne Konsistenz (Cronbach Alpha) lag im Bereich von 0,82 für die gesunde Kontrollgruppe und 0,93 für die gesamte Patientengruppe. Es zeigte sich kein Geschlechtereffekt, aber das Alter hatte einen negativen Effekt auf die VVT Leistung. Der VVT konnte erfolgreich zwischen gesunden Kontrollen und MCI-Patienten, Patienten mit AD und PD-Patienten differenzieren.

Schlussfolgerung

Der VVT zeigte eine zufriedenstellende Gültigkeit und Zuverlässigkeit und kann problemlos in der klinischen Praxis angewendet werden. Es stellt somit ein neues Verfahren dar, um visuell-konstruktive Probleme bei Patienten mit kognitiven Störungen zu identifizieren.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Albert MS, Dekosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–9. doi:S1552-5260(11)00104-X [pii]10.1016/j.jalz.2011.03.008.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Litvan I, Goldman JG, Troester AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines. Mov Disord. 2012;27(3):349–56. doi:10.1002/mds.24893.

    Article  PubMed Central  PubMed  Google Scholar 

  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. vol. DSM 5. Arlington: American Psychiatric Publishing; 2013.

    Google Scholar 

  4. Lezak MD. Neuropsychological assessment. New York: Oxford University Press; 1995.

    Google Scholar 

  5. Kleist K. Gehirnpathologie. Leipzig: Barth; 1934.

    Google Scholar 

  6. Foerster S, Teipel S, Zach C, Rominger A, Cumming P, la Fougere C, et al. FDG-PET mapping the brain substrates of visuo-constructive processing in Alzheimers disease. J Psychiatric Res. 2010;44(7):462–9. doi:10.1016/j.jpsychires.2009.09.012.

    Article  Google Scholar 

  7. Folstein M, Folstein S., McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.

    Article  CAS  PubMed  Google Scholar 

  8. Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry. 2000;15(6):548–61. doi:10.1002/1099-1166(200006)15:6<548::aid-gps242>3.3.co;2-l.

    Article  CAS  PubMed  Google Scholar 

  9. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.

    Article  PubMed  Google Scholar 

  10. Rey A. The psychological examination in cases of traumatic encephalopathy. Arch Psychol. 1941;28:215–85.

    Google Scholar 

  11. Osterrieth PA. Test of copying a complex figure: contribution to the study of perception and memory. Arch Psychol. 1944;30:206–356.

    Google Scholar 

  12. Shon JM, Lee DY, Seo EH, Sohn BK, Kim JW, Park SY, et al. Functional neuroanatomical correlates of the executive clock drawing task (clox) performance in Alzheimer’s disease: a FDG-PET study. Neuroscience. 2013;246:271–80. doi:10.1016/j.neuroscience.2013.05.008.

    Article  CAS  PubMed  Google Scholar 

  13. Price CC, Cunningham H, Coronado N, Freedland A, Cosentino S, Penney DL, et al. Clock drawing in the montreal cognitive assessment: recommendations for dementia assessment. Dementia Geriatr Cogniti Disord. 2011;31(3):179–87. doi:10.1159/000324639.

    Article  Google Scholar 

  14. Zec RF, Landreth ES, Vicari SK, Belman J, Feldman E, Andrise A, et al. Alzheimer-Disease Assessment Scale—a subtest analysis. Alzheimer Dis Assoc Disord. 1992;6(3):164–81. doi:10.1097/00002093-199206030-00004.

    Article  CAS  PubMed  Google Scholar 

  15. Lee H, Swanwick GR, Coen RF, Lawlor BA. Use of the clock drawing task in the diagnosis of mild and very mild Alzheimer’s disease. Int psychogeriatr/IPA. 1996;8(3):469–76. doi:10.1017/s1041610296002827.

    Article  CAS  Google Scholar 

  16. Connor DJ, Seward JD, Bauer JA, Golden KS, Salmon DP. Performance of three clock scoring systems across different ranges of dementia severity. Alzheimer Dis Assoc Disord. 2005;19(3):119–27. doi:10.1097/01.wad.0000174948.77113.a6.

    Article  PubMed  Google Scholar 

  17. Sevigny JJ, Peng Y, Liu L, Lines CR. Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial. Am J Alzheimers Dis Other Dementias. 2010;25(2):119–24. doi:10.1177/1533317509350298.

    Article  Google Scholar 

  18. Cormack F, Aarsland D, Ballard C, Tovee MJ. Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer’s disease, Parkinson’s disease and Parkinson’s disease with dementia. Int J Geriatr Psychiatry. 2004;19(4):371–7. doi:10.1002/gps.1094.

    Article  PubMed  Google Scholar 

  19. Pusswald G, Moser D, Gleiss A, Janzek-Hawlat S, Auff E, Dal-Bianco P, et al. Prevalence of mild cognitive impairment subtypes in patients attending a memory outpatient clinic-comparison of two modes of mild cognitive impairment classification. Results of the Vienna conversion to dementia study. Alzheimers Dementia. 2013;9(4):366–76. doi:10.1016/j.jalz.2011.12.009.

    Article  Google Scholar 

  20. Lehrner J, Zach H, Moser D, Gleiss A, Auff E, Pirker W, et al. Prevalence of mild cognitive impairment subtypes in patients with Parkinson’s disease—comparison of two modes of classification. Zeitschrift für Neuropsychologie. 2014;25(1):49–63. doi:10.1024/1016-264X/a000116.

    Article  Google Scholar 

  21. Lehrner J, Maly J, Gleiß A, Auff E, Dal-Bianco P. The Vienna Neuropsychological Test Battery (VNTB) for detecting dementia—standardization, norms, and validation. Psychologie in Österreich. 2007;4(5):358–65.

    Google Scholar 

  22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer disease. Neurology. 1984;34:939–44.

    Article  CAS  PubMed  Google Scholar 

  23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 2000.

    Google Scholar 

  24. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinsons’s disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745–52. doi:10.1136/jnnp.51.6.745.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–94. doi:10.1111/j.1365-2796.2004.01388.xJIM1388 [pii].

    Article  CAS  PubMed  Google Scholar 

  26. Ivnik R, Malec JF, Smith GD, et.al. Mayo’s older Americans normative studies: WAIS-R, WMS-R and AVLT norms for ages 56 through 97. Clin Neuropsychol. 1992;6:1–104.

    Article  Google Scholar 

  27. Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer’s disease assessment scale that broaden its scope. The Alzheimer’s disease cooperative study. Alzheimer Dis Assoc Disord. 1997;11 Suppl. 2:S13–21.

    Article  PubMed  Google Scholar 

  28. Libon DJ, Malamut BL, Swenson R, Sands LP, Cloud BS. Further analyses of clock drawings among demented and nondemented older subjects. Archives clin neuropsychol: the official J Nat Acad Neuropsychol. 1996;11(3):193–205. doi:10.1016/0887-6177(95)00026-7.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Sandra Kogler for proof reading the manuscript. A German version and an English version of the VVT are available free of charge from the authors.

Conflict of interest

Prof. Lehrner, Mag. Krakhofer, Prof. Lamm, Dr. Macher, Dr. Moser, Dr. Klug, Dr. Pusswald, Prof. Dal-Bianco, Prof. Pirker, and Prof. Auff report no disclosures.

Prof. Lehrner: Study concept and design, study supervision, acquisition of data, critical revision of the manuscript for important intellectual content.

Mag. Krakhofer: analysis and interpretation, drafting the manuscript

Prof. Lamm: critical revision of the manuscript for important intellectual content

Dr. Macher, Dr. Moser, and Mag. Klug: acquisition of data.

Prof. Dal-Bianco, Prof. Pirker, Prof. Auff, and Dr. Pusswald: critical revision of the manuscript for important intellectual content

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Johann Lehrner PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lehrner, J., Krakhofer, H., Lamm, C. et al. Visuo-constructional functions in patients with mild cognitive impairment, Alzheimer’s disease, and Parkinson’s disease. Neuropsychiatr 29, 112–119 (2015). https://doi.org/10.1007/s40211-015-0141-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40211-015-0141-2

Keywords

Schlüsselwörter

Navigation